- REPORT SUMMARY
- TABLE OF CONTENTS
-
The worldwide Aurora Kinase B market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 5.3% during the forecast period.
This report presents the market size and development trends by detailing the Aurora Kinase B market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Aurora Kinase B market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Aurora Kinase B industry and will help you to build a panoramic view of the industrial development.
Aurora Kinase B Market, By Type:
AZD-2811
CS-2164
Danusertib
Ilorasertib
NMI-900
Others
Aurora Kinase B Market, By Application:
Anaplastic Large Cell Lymphoma
Kidney Cancer
Lung Cancer
Prostate Cancer
Others
Some of the leading players are as follows:
Advenchen Laboratories LLC
Aeterna Zentaris Inc
AstraZeneca Plc
Cielo Therapeutics Inc
Chipscreen Biosciences Ltd
AbbVie Inc
Amgen Inc
Sareum Holdings Plc
Sanofi
Geographically, Major regions are analyzed in details are as follows:
-
North America
-
Europe
-
Asia Pacific
-
Latin America
-
Middle East & Africa
Table of Contents
1 Methodology and Scope
-
1.1 Market Segmentation & Scope
-
1.1.1 Technology Type
-
1.1.2 Product
-
1.1.3 Application
-
1.1.4 Regional scope
-
1.1.5 Estimates and forecast timeline
-
1.2 Research Methodology
-
1.3 Information Procurement
-
1.3.1 Purchased database
-
1.3.2 Internal database
-
1.3.3 Secondary sources
-
1.3.4 Primary research
-
1.3.5 Details of primary research
-
1.4 Information or Data Analysis
-
1.4.1 Data analysis models
-
1.5 Market Formulation & Validation
-
1.6 Model Details
-
1.6.1 Commodity flow analysis
-
1.6.2 Volume price analysis
-
1.7 List of Secondary Sources
-
1.8 List of Abbreviations
2 Executive Summary
-
2.1 Market Outlook
-
2.2 Segment Outlook
3 Market Variables, Trends, & Scope
-
3.1 Market Lineage Outlook
-
3.1.1 Parent market outlook
-
3.1.2 Ancillary market outlook
-
3.2 Market Segmentation
-
3.2.1 Analysis
-
3.3 Market Dynamics
-
3.3.1 Market driver analysis
-
3.3.2 Market restraint analysis
-
3.3.3 Industry opportunities
-
3.4 Penetration & Growth Prospect Mapping
-
3.4.1 Penetration & growth prospect mapping analysis
-
3.5 Business Environment Analysis Tools
-
3.5.1 Porter's five forces analysis
-
3.5.2 PESTLE analysis
-
3.5.3 Major deals & strategic alliances analysis
4 Aurora Kinase B Market: Technology Type Analysis
-
4.1 Aurora Kinase B Technology Type Market Share Analysis, 2018 & 2026
-
4.2 Aurora Kinase B Technology Type Market: Segment Dashboard
-
4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment
4.3.1 AZD-2811
4.3.2 CS-2164
4.3.3 Danusertib
4.3.4 Ilorasertib
4.3.5 NMI-900
4.3.6 Others
5 Aurora Kinase B Market: Product Analysis
-
5.1 Aurora Kinase B Product Market Share Analysis, 2018 & 2026
-
5.2 Aurora Kinase B Product Market: Segment Dashboard
-
5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment
6 Aurora Kinase B Market: Application Analysis
-
6.1 Aurora Kinase B Application Market Share Analysis, 2018 & 2026
-
6.2 Aurora Kinase B Application Market: Segment Dashboard
-
6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment
6.3.1 Anaplastic Large Cell Lymphoma
6.3.2 Kidney Cancer
6.3.3 Lung Cancer
6.3.4 Prostate Cancer
6.3.5 Others
7 Aurora Kinase B Market: Regional Analysis
-
7.1 Aurora Kinase B Regional Market Share Analysis, 2018 & 2026
-
7.2 Aurora Kinase B Regional Market: Segment Dashboard
-
7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)
-
7.4 List of Players at Regional Level
-
7.4.1 North America
-
7.4.2 Europe
-
7.4.3 Asia Pacific
-
7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
-
7.5.1 North America
-
7.5.2 Europe
-
7.5.3 Asia Pacific
-
7.5.4 Latin America
-
7.5.5 MEA
-
7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026
-
7.6.1 North America
-
7.6.2 Europe
-
7.6.3 Asia Pacific
-
7.6.4 Latin America
-
7.6.5 Middle East & Africa
8 Competitive Analysis
-
8.1 Recent Developments & Impact Analysis, by Key Market Participants
-
8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)
-
8.3 Vendor Landscape
-
8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)
9 Company Profiles
9.1 Advenchen Laboratories LLC
9.1.1 Advenchen Laboratories LLC Company overview
9.1.2 Financial performance
9.1.3 Product benchmarking
9.1.4 Strategic initiatives
9.1.5 SWOT analysis
9.2 Aeterna Zentaris Inc
9.2.1 Aeterna Zentaris Inc Company overview
9.2.2 Financial performance
9.2.3 Product benchmarking
9.2.4 Strategic initiatives
9.2.5 SWOT analysis
9.3 AstraZeneca Plc
9.3.1 AstraZeneca Plc Company overview
9.3.2 Financial performance
9.3.3 Product benchmarking
9.3.4 Strategic initiatives
9.3.5 SWOT analysis
9.4 Cielo Therapeutics Inc
9.4.1 Cielo Therapeutics Inc Company overview
9.4.2 Financial performance
9.4.3 Product benchmarking
9.4.4 Strategic initiatives
9.4.5 SWOT analysis
9.5 Chipscreen Biosciences Ltd
9.5.1 Chipscreen Biosciences Ltd Company overview
9.5.2 Financial performance
9.5.3 Product benchmarking
9.5.4 Strategic initiatives
9.5.5 SWOT analysis
9.6 AbbVie Inc
9.6.1 AbbVie Inc Company overview
9.6.2 Financial performance
9.6.3 Product benchmarking
9.6.4 Strategic initiatives
9.6.5 SWOT analysis
9.7 Amgen Inc
9.7.1 Amgen Inc Company overview
9.7.2 Financial performance
9.7.3 Product benchmarking
9.7.4 Strategic initiatives
9.7.5 SWOT analysis
9.8 Sareum Holdings Plc
9.8.1 Sareum Holdings Plc Company overview
9.8.2 Financial performance
9.8.3 Product benchmarking
9.8.4 Strategic initiatives
9.8.5 SWOT analysis
9.9 Sanofi
9.9.1 Sanofi Company overview
9.9.2 Financial performance
9.9.3 Product benchmarking
9.9.4 Strategic initiatives
9.9.5 SWOT analysis
The List of Tables and Figures (Totals 90 Figures and 124 Tables)
Figure AZD-2811 Aurora Kinase B market, 2015 - 2026 (USD Million)
Figure CS-2164 Aurora Kinase B market, 2015 - 2026 (USD Million)
Figure Danusertib Aurora Kinase B market, 2015 - 2026 (USD Million)
Figure Ilorasertib Aurora Kinase B market, 2015 - 2026 (USD Million)
Figure NMI-900 Aurora Kinase B market, 2015 - 2026 (USD Million)
Figure Others Aurora Kinase B market, 2015 - 2026 (USD Million)
Figure Anaplastic Large Cell Lymphoma market, 2015 - 2026 (USD Million)
Figure Kidney Cancer market, 2015 - 2026 (USD Million)
Figure Lung Cancer market, 2015 - 2026 (USD Million)
Figure Prostate Cancer market, 2015 - 2026 (USD Million)
Figure Others market, 2015 - 2026 (USD Million)
-
Table List of players in North America
-
Table List of players in Europe
-
Table List of players in Asia Pacific
-
Table SWOT analysis
-
Table North America Aurora Kinase B market, by country, 2015 - 2026 (USD Million)
-
Table North America Aurora Kinase B market, by type, 2015 - 2026 (USD Million)
-
Table North America Aurora Kinase B market, by product, 2015 - 2026 (USD Million)
-
Table North America Aurora Kinase B market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.S. Aurora Kinase B market, by type, 2015 - 2026 (USD Million)
-
Table U.S. Aurora Kinase B market, by product, 2015 - 2026 (USD Million)
-
Table U.S. Aurora Kinase B market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Canada Aurora Kinase B market, by type, 2015 - 2026 (USD Million)
-
Table Canada Aurora Kinase B market, by product, 2015 - 2026 (USD Million)
-
Table Canada Aurora Kinase B market, by application, 2015 - 2026 (USD Million)
-
Table Europe Aurora Kinase B market, by country, 2015 - 2026 (USD Million)
-
Table Europe Aurora Kinase B market, by type, 2015 - 2026 (USD Million)
-
Table Europe Aurora Kinase B market, by product, 2015 - 2026 (USD Million)
-
Table Europe Aurora Kinase B market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.K. Aurora Kinase B market, by type, 2015 - 2026 (USD Million)
-
Table U.K. Aurora Kinase B market, by product, 2015 - 2026 (USD Million)
-
Table U.K. Aurora Kinase B market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Germany Aurora Kinase B market, by type, 2015 - 2026 (USD Million)
-
Table Germany Aurora Kinase B market, by product, 2015 - 2026 (USD Million)
-
Table Germany Aurora Kinase B market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table France Aurora Kinase B market, by type, 2015 - 2026 (USD Million)
-
Table France Aurora Kinase B market, by product, 2015 - 2026 (USD Million)
-
Table France Aurora Kinase B market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Italy Aurora Kinase B market, by type, 2015 - 2026 (USD Million)
-
Table Italy Aurora Kinase B market, by product, 2015 - 2026 (USD Million)
-
Table Italy Aurora Kinase B market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Spain Aurora Kinase B market, by type, 2015 - 2026 (USD Million)
-
Table Spain Aurora Kinase B market, by product, 2015 - 2026 (USD Million)
-
Table Spain Aurora Kinase B market, by application, 2015 - 2026 (USD Million)
-
Table Asia Pacific Aurora Kinase B market, by country, 2015 - 2026 (USD Million)
-
Table Asia Pacific Aurora Kinase B market, by type, 2015 - 2026 (USD Million)
-
Table Asia Pacific Aurora Kinase B market, by product, 2015 - 2026 (USD Million)
-
Table Asia Pacific Aurora Kinase B market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table China Aurora Kinase B market, by type, 2015 - 2026 (USD Million)
-
Table China Aurora Kinase B market, by product, 2015 - 2026 (USD Million)
-
Table China Aurora Kinase B market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Japan Aurora Kinase B market, by type, 2015 - 2026 (USD Million)
-
Table Japan Aurora Kinase B market, by product, 2015 - 2026 (USD Million)
-
Table Japan Aurora Kinase B market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table India Aurora Kinase B market, by type, 2015 - 2026 (USD Million)
-
Table India Aurora Kinase B market, by product, 2015 - 2026 (USD Million)
-
Table India Aurora Kinase B market, by application, 2015 - 2026 (USD Million)
-
Table Latin America Aurora Kinase B market, by country, 2015 - 2026 (USD Million)
-
Table Latin America Aurora Kinase B market, by type, 2015 - 2026 (USD Million)
-
Table Latin America Aurora Kinase B market, by product, 2015 - 2026 (USD Million)
-
Table Latin America Aurora Kinase B market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Brazil Aurora Kinase B market, by type, 2015 - 2026 (USD Million)
-
Table Brazil Aurora Kinase B market, by product, 2015 - 2026 (USD Million)
-
Table Brazil Aurora Kinase B market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Mexico Aurora Kinase B market, by type, 2015 - 2026 (USD Million)
-
Table Mexico Aurora Kinase B market, by product, 2015 - 2026 (USD Million)
-
Table Mexico Aurora Kinase B market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Argentina Aurora Kinase B market, by type, 2015 - 2026 (USD Million)
-
Table Argentina Aurora Kinase B market, by product, 2015 - 2026 (USD Million)
-
Table Argentina Aurora Kinase B market, by application, 2015 - 2026 (USD Million)
-
Table MEA Aurora Kinase B market, by country, 2015 - 2026 (USD Million)
-
Table MEA Aurora Kinase B market, by type, 2015 - 2026 (USD Million)
-
Table MEA Aurora Kinase B market, by product, 2015 - 2026 (USD Million)
-
Table MEA Aurora Kinase B market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table South Africa Aurora Kinase B market, by type, 2015 - 2026 (USD Million)
-
Table South Africa Aurora Kinase B market, by product, 2015 - 2026 (USD Million)
-
Table South Africa Aurora Kinase B market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Nigeria Aurora Kinase B market, by type, 2015 - 2026 (USD Million)
-
Table Nigeria Aurora Kinase B market, by product, 2015 - 2026 (USD Million)
-
Table Nigeria Aurora Kinase B market, by application, 2015 - 2026 (USD Million)
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Company market position analysis
Table Company Profiles
Table Advenchen Laboratories LLC Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Aeterna Zentaris Inc Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table AstraZeneca Plc Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Cielo Therapeutics Inc Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Chipscreen Biosciences Ltd Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table AbbVie Inc Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Amgen Inc Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Sareum Holdings Plc Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Sanofi Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
-